{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Sugar Land",
      "state": "TX",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "73710",
      "recalling_firm": "QuVa Pharma, Inc.",
      "address_1": "1075 W Park One Dr Ste 100",
      "address_2": "N/A",
      "postal_code": "77478-2576",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "CA",
      "recall_number": "D-1066-2016",
      "product_description": "PHENYLephrine 1 mg/10 mL (100 mcg/mL) in 0.9% Sodium Chloride, 10 mL syringe, packaged in 24 syringes per case, Rx only,  Healix Infusion Therapy Inc, 1075 W Park One Drive, Suite 200, Sugar Land Texas 77478, Product Code: 75901-1205-35.",
      "product_quantity": "20 cases",
      "reason_for_recall": "Labeling: Label Error on Declared Strength. Product has correct label on the syringe and the case but some units are incorrectly labeled as .4 mg/10 mL (40 mcg/ml) on the light protective overwrap of each syringe.",
      "recall_initiation_date": "20160330",
      "center_classification_date": "20160706",
      "termination_date": "20161129",
      "report_date": "20160713",
      "code_info": "Lot #: 14312-0, Exp 4/15/2016"
    }
  ]
}